Zhu Zheng I, Clancy Colleen E
Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S47-50. doi: 10.1016/j.jelectrocard.2007.05.033.
In the past two decades, mutations in cardiac ion channels have been shown to underlie a number of rare inherited cardiac arrhythmias. Defects in cardiac Na(+) channels can disrupt channel gating and cause electrical abnormalities that increase susceptibility to cardiac arrhythmia. Dozens of mutations have been identified in the gene SCN5A, which encodes the alpha subunit of the cardiac Na(+) channel, and have been causally linked to a wide spectrum of cardiac arrhythmic disorders. An important step in understanding genetically based arrhythmias is to clarify the relationship between molecular defects and the disruption of the delicate balance of dynamic interactions at the cell, tissue, and organ levels. Here, we provide an overview of cardiac Na(+) channel mutations that are associated with inherited arrhythmia syndromes. We also address pros and cons of current methodologies used to understand how specific genetic defects disrupt channel-gating kinetics and underlie cardiac arrhythmia. Finally, we discuss effects of mutations on predictability and efficacy of treatment with Na(+) channel-blocking drugs.
在过去二十年中,已证明心脏离子通道突变是多种罕见遗传性心律失常的基础。心脏钠通道缺陷可破坏通道门控,导致电异常,增加心律失常易感性。已在编码心脏钠通道α亚基的基因SCN5A中鉴定出数十种突变,并已将其与广泛的心律失常疾病因果关联。理解基于基因的心律失常的一个重要步骤是阐明分子缺陷与细胞、组织和器官水平动态相互作用微妙平衡破坏之间的关系。在此,我们概述了与遗传性心律失常综合征相关的心脏钠通道突变。我们还讨论了用于理解特定基因缺陷如何破坏通道门控动力学并成为心律失常基础的当前方法的优缺点。最后,我们讨论突变对钠通道阻滞剂治疗的可预测性和疗效的影响。